English
Select site language

Purevax RCPCh FeLV (Attenuated feline rhinotracheitis herpesvirus...) – Conditions or restrictions regarding supply and use - QI06AX

Updated on site: 09-Feb-2018

Medication name: Purevax RCPCh FeLV
ATC: QI06AX
Substance: Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain), inactivated feline Calicivirosis antigens (FCV 431 and G1 strains), attenuated Chlamydophila felis (905 strain), attenuated feline panleucopenia virus (PLI IV), FeLV recombinant canarypox viru
Manufacturer: Merial

A. MANUFACTURERS OF THE BIOLOGICAL ACTIVE SUBSTANCES AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE

Name and address of the manufacturers of the biological active substances

Merial

Laboratory of Lyon Porte des Alpes Rue de l’aviation

69800 SAINT-PRIEST FRANCE

Merial

Laboratory of Lyon Gerland

254, Avenue Marcel Mérieux

69007 LYON

FRANCE

Name and address of the manufacturer responsible for batch release

Merial

Laboratory of Lyon Porte des Alpes Rue de l’aviation

69800 SAINT-PRIEST FRANCE

B.CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE

Veterinary medicinal product subject to prescription.

C.STATEMENT OF THE MRLs

Not applicable.

Comments